| Literature DB >> 28750014 |
Marcio Clementino de Souza Santos1,2, Luiz Carlos de Lima Silveira2,3,4, Sílvia Cristina Garcia Moura-Tonello5, Alberto Porta6,7, Aparecida Maria Catai5, Givago da Silva Souza2,3.
Abstract
OBJECTIVE: To evaluate the heart rate variability (HRV) in patients with multibacillary leprosy using dynamic linear and nonlinear analysis.Entities:
Mesh:
Year: 2017 PMID: 28750014 PMCID: PMC5531509 DOI: 10.1371/journal.pone.0180677
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Values of the age, anthropometric characteristics, drug therapy and dosage of medicine in leprosy group volunteers.
| LeprosyGroup | Age | Body Mass (Kg) | Height (m) | BMI (Kg/m2) | Drug Therapy | Dosage (mg) |
|---|---|---|---|---|---|---|
| 42 | 65 | 1.7 | 22.49 | Prednisone | 30 | |
| 36 | 63 | 1.65 | 23.16 | Prednisone | 20 | |
| 52 | 72.5 | 1.7 | 25.08 | Prednisone | 50 | |
| 53 | 74 | 1.72 | 25.08 | Prednisone | 20 | |
| 35 | 70.3 | 1.7 | 24.32 | Prednisone + MDT | 30 | |
| 23 | 79 | 1.7 | 27.33 | Prednisone | 20 | |
| 55 | 65 | 1.65 | 23.89 | Prednisone | 30 | |
| 54 | 57 | 1.62 | 21.75 | Nd | - | |
| 40 | 85.7 | 1.63 | 32.33 | Prednisone | 5 | |
| 36 | 71 | 1.74 | 23.5 | Prednisone | 60 | |
| 34 | 81 | 1.78 | 25.63 | Prednisone + Thalidomide | 20 + 100 | |
| 55 | 62 | 1.65 | 22.79 | Prednisone | 20 | |
| 26 | 46 | 1.55 | 19.16 | Prednisone | 5 | |
| 29 | 63 | 1.75 | 20.58 | Prednisone | 5 | |
| 26 | 67 | 1.65 | 24.63 | Prednisone | 5 | |
| 42 | 76 | 1.71 | 26.02 | Nd | - | |
| 41 | 63.2 | 1.65 | 23.23 | Prednisone | 70 | |
| 38 | 56 | 1.51 | 24.56 | Prednisone | 20 | |
| 47 | 70 | 1.7 | 24.22 | Prednisone | 5 | |
| 22 | 62 | 1.52 | 26.83 | Nd | - | |
| 36 | 78 | 1.78 | 24.68 | Nd | - | |
MDT, Multi droug therapy; nd, no drugs. SD, standard deviation
Anthropometric characteristics of the volunteer groups.
| Characteristics | Control Group | Leprosy Group | P-value |
|---|---|---|---|
| 36.24 ± 12.64 | 39.14 ± 10.58 | 0.212 | |
| 75.79 ± 10.62 | 66.76 ± 9.24 | 0.058 | |
| 1.73 ± 0.09 | 1.67 ± 0.08 | 0.063 | |
| 25.45 ± 2.84 | 24.35 ± 2.66 | 0.100 |
Data are reported as means ± standard deviation. BMI = body mass index
R-R intervals (ms) values of the groups.
| R-R interval (ms) | ||
|---|---|---|
| Position | CG | LG |
| 870 ± 122 | 848 ± 143 | |
| 843 ± 106 | 796 ±137 | |
Data are reported as means ± standard deviation of RRi (ms), CG: control group; LG: leprosy group.
* p<0,05 compared to the supine position.
† p<0,05 compared to the same position in the control group.
Fig 1Linear analysis of the HRV from control group and leprosy groups for (A) low frequencies and (B) high frequencies in normalized units (nu).
Leprosy patients had higher LFnu values (lower HFnu values) than controls in the supine position. Both groups were influenced by the change from supine to sitting position. LFnu values increased and HFnu values decreased in the sitting position compared to supine position for both groups. * p<0.05 intragroup; † p<0.05 intergroup.
Fig 2Non-linear analysis of the HRV for (A) 0V%, (B) 1V%, (C) 2LV%, (D) 2UV%, (E) Shannon entropy, and (F) NCI.
All the indexes showed differences between control and leprosy groups. The leprosy group in most of the indexes showed no differences between the sitting and supine positions. * p<0.05 intragroup; † p<0.05 intergroup.